Jagsonpal Pharmaceuticals
JAGSNPHARM · Pharma > Pharmaceuticals & Drugs · Chairman: R P S Kochhar · MD: R P S Kochhar · Listing date: Sept. 12, 1996 · New Delhi · http://www.jagsonpal.com

Stock Price vs Company Growth
1d
2.4%
1w
1.2%
1m
2.0%
3m
10.5%
6m
7.4%
1y
23.3%
5y
56.6%
10y
27.6%
all
21.2%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 213 2.4%
196
261
Company Overview

Sales
283 Cr
Growth: 20.6%
Profit after Tax
38.8 Cr
Growth: 3.0%
Small Cap
1,421 Cr
P/E: 33.6x
Industry P/E: 33.3x
Fundamentals

Sales (Cr) ₹ 283
Growth 20.6%
EBITDA 19.5%
P/S 5.0x
Dividend 1.2%
P/E 33.6x
Book Value ₹ 39.4
PEG Ratio 1.7x
ROE 16.0%
P/B 5.5x
Shareholding Pattern

Institutions
Promoters
Aresko Progressive Private Limited
65.71 %
Rajpal Singh Kochhar
4.63 %
Others
Investor Education And Protection Fund Authority
1.56 %
Sanjiv Kumar Dudeja
1.41 %
Lincoln P Coelho
1.16 %
Increase    Decrease    No change
Company Profile Detailed

In 1964 Jagsonpal started from humble beginnings with Jagmohan S. Kochhar operating a chemists shop in Delhi. Soon he expanded into making formulations. Mr. Kochhar’s vision was to spread health and healing in India on a larger scale. He was at the helm of the company from its inception, through the startup phase. Even though Jagsonpal was a small business at the time, his vision was to create one of India’s premiere pharmaceutical companies.
Investors (23)